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The activity of avian sarcoma leukemia virus (ASLV) protease (PR) prior to its release from the precursor protein was
determined by introducing mutations at the cleavage site between PR and the adjacent upstream nucleocapsid (NC) protein.
Gag DNA fragments containing these mutations were cloned into expression vectors and introduced into Escherichia coli
in which the ASLV proteins were expressed. The dipeptide NC-PR containing these mutations did not undergo autoprocessing
when expressed in bacterial cells and the fused proteins were devoid of enzymatic activity. However, when the whole Gag
polyprotein containing these mutations was expressed in bacterial cells, other PR cleavage sites in the viral Gag polyprotein
underwent normal cleavage, indicating that the release of free PR is not a prerequisite for correct processing of the ASLV
Gag precursor. q 1995 Academic Press, Inc.
INTRODUCTION preventing cleavage between the nucleocapsid (NC) and
PR inhibits the processing of ASLV precursors expressed
The protease (PR) of avian sarcoma leukemia virus
in avian and mammalian cells and abrogates viral pro-
(ASLV), encoded at the 3* terminus of the gag gene, is
duction. On the other hand, cleavage site mutations be-
synthesized as part of both the Gag and the Gag-Pol
tween p6Pol and PR do not affect processing of HIV-1
polyproteins. PR is probably necessary for catalyzing the
precursors and the viral polyproteins are expressed cor-
processing and copackaging of Gag and Gag-Pol precur-
rectly in vitro and in bacterial cells (Kotler et al., 1992;
sors (Stewart and Vogt, 1991; Craven et al., 1991; Ross
Zybarth et al., 1994; Co et al., 1994). We were interested,
et al., 1991; Bennet et al., 1991). However, the PR in
therefore, in determining whether the release of ASLV
the Gag-Pol polyprotein is also engaged in autocatalytic
PR from the precursor is a prerequisite for the enzymatic
cleavage (Oertle et al., 1992) and is responsible for acti-
activity.
vation of reverse transcriptase (RT) (Craven et al., 1991).
We introduced mutations into the sequence of the
It was found that in avian viruses the PR released from
ASLV genome encoding for the cleavage site between
Gag-Pol polyprotein contains 1–2 amino acid residues
PR and NC. Our results show that Gag proteins con-
more than that obtained from the Gag polyprotein (Arad
taining these mutations and expressed in Escherichia
et al., 1995; Brynda et al., 1995). Thus, it may be assumed
coli undergo autoprocessing and possess PR activity.
that both ASLV Gag and Gag-Pol precursors are cleaved
by their integral PR. In contrast, the Gag precursor of
MATERIALS AND METHODSmammalian retroviruses is processed in trans by a PR
present in the larger polyproteins. Bacterial cells. E. coli strain MC1061 was used as a
Very little is known about the structure and function of host for vectors expressing ASLV PR and NC–PR (Casa-
PR in retroviral polyproteins, although it has been sug- daban and Cohen, 1980). This strain contains the plasmid
gested that both properties are influenced by the proteins pRK248cIts, which directs the expression of a tempera-
adjacent to PR (Partin et al., 1991; Zybarth et al., 1994; ture-sensitive bacteriophage l repressor protein (Crowl
Phylip et al., 1992; Kotler et al., 1992). Possibly, a signifi- et al., 1985). E. coli BU8049, which also produces a tem-
cant part of the processing is catalyzed by the PR that perature-sensitive l repressor protein, was used as a
is still part of the polyprotein and not by the free form. It host for plasmid intermediates in the construction of the
is not clear whether release of ASLV PR from the precur- ASLV gag expression plasmids (Tabor and Richardson,
sors is a prerequisite for its activity (Burstein et al., 1992; 1987).
Kotler et al., 1992). Construction of bacterial expression plasmids. Bacte-
Burstein et al. (1992) demonstrated that a mutation rial plasmids expressing ASLV PR, NC, and NC–PR were
derived from the pEV-vrf plasmid (Crowl et al., 1985). This
plasmid contains the PLOL region of bacteriophage l and1 To whom correspondence and reprint requests should be ad-
dressed. sites for the binding of ribosomes and for translational
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FIG. 1. Expression and processing of ASLV polypeptides by E. coli. Lysates of E. coli strains expressing the indicated polypeptides (see text and
Table 1 for a more complete description of the ASLV NC-PR polypeptides) were fractionated on 15% SDS–polyacrylamide gels and transferred to
nitrocellulose filters. ASLV peptides were detected following reaction with an antibody to PR (A) or antisera specific for NC (B), by the addition of
I125-protein A. Positions of PR, NC, and NC-PR are indicated (PR and NC). Two truncated NC (D)–PR fusion proteins (as described by Kotler et al.,
1988b) were included as controls.
initiation. Mutations were introduced by site-directed oli- EDTA, 25 mM Tris (pH 8.0), and 4 mg/ml lysozyme. The
suspensions were incubated for 10 min on ice and sub-gonucleotide mutagenesis (Morinaga et al., 1984) into
the plasmid-expressing NC–PR at the position encoding jected to three 15-sec bursts of sonication. The bacterial
lysates were centrifuged for 30 min at 30,000 g. Thethe NC–PR cleavage site. In mutant CS1, a Ser codon
was changed to Ile just upstream of the cleavage site resulting pellets were dissolved in 6 M guanidine-hydro-
chloride, pH 8.0, and acidified to pH 2 by the addition ofbetween NC and PR. This alters the normal cleavage site
sequence Pro Ala Val Ser f Leu Ala Met Thr Met to Pro trifluoroacetic acid (TFA). The dissolved proteins were
fractionated by reverse-phase high-pressure liquid chro-Ala Val Ile f Leu Ala Met Thr Met. In the CS2 mutant,
two codons were deleted just upstream of the Ser codon, matography (RP-HPLC) on a 19 1 150 mm m-Bondapack
C18 column (Waters Associates, Inc.) using a linear gradi-and the Ser codon was converted to an Ile codon. The
resulting NC–PR junction had the sequence Pro Ile f ent (0–60%) of acetonitrile in the presence of 0.05% TFA.
Fractions from the RP-HPLC column were lyophilized andLeu Ala Met Thr Met. To monitor introduction of the muta-
tions into the expression plasmids, the oligonucleotides dissolved in 2 M guanidine-hydrochloride, 100 mM Tris–
HCl, pH 8.0, to a concentration of 200–300 mg/ml, andwere designed to include diagnostic restriction sites
(EcoRV and SspI). refolded as follows: 1 vol of the protein solution was
diluted with 2 vol of refolding buffer (20 mM PIPES, pHPlasmid pSJHgag (a generous gift from J. M. Coffin) is
a derivative of pT7-13 (BRL). pSJHgag contains a SacI– 7.0, containing 100 mM NaCl, 10% glycerol, 1 mM EDTA).
The fractions were dialyzed against the refolding bufferHindIII fragment [(nucleotides 255–2740) (Schwartz et
al., 1983)] from the ASLV Prague C strain, which codes for 4 hr at 47. The dialyzed fractions having the highest
specific activity were collected and the protein concen-for the entire gag gene. In the pSJHgag plasmid, the
expression of ASLV proteins is under the control of a T7 tration was determined with the aid of commercial Bio-
Rad kits.promoter. The cleavage site and active site mutations
originally introduced into the pNC–PR plasmid were Preparation of bacterial extracts for determination of
enzymatic activity. Induced and uninduced E. coli cul-cloned into the pSJHgag plasmid by substituting the
BamHI to EcoRI fragments for the corresponding seg- tures (1.75 ml) were collected by centrifugation and re-
suspended in 400 ml of 4% toluene, 10 mM Tris–HCl (pHments (see Table 1).
Production of viral proteins. ASLV polypeptides were 8.0), 5 mM mercaptoethanol, 0.1 mM EDTA, and 0.1%
Triton X-100. Bacterial cell suspensions were vortexedproduced in bacterial cells grown on M9 media supple-
mented with casamino acids and glucose to an OD600 of for 3 min and incubated for 20 min at 377. Intact cells
and debris were pelleted by centrifugation. Supernatants0.4 by shifting cultures from 307 to 427 for 3 to 6 hr, as
described previously (Kotler et al., 1988a and 1988b). were lyophilized and dissolved in 50 ml of distilled water,
of which 4 ml were assayed (Kotler et al., 1988a).Purification of PR. ASLV PR was purified as described
previously (Copeland and Oroszlan, 1988). Bacterial cells Peptide cleavage assay. Oligopeptides were synthe-
sized and characterized as described (Kotler et al.,expressing PR were collected by centrifugation and the
pellets were suspended in 50 mM dextrose, 10 mM 1988a, 1989). Assays were performed in 0.25 M potas-
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the latter was inactivated by replacing Asp by Ile at the
active site, demonstrating that cleavage requires an ac-
tive PR and is not the result of hydrolysis by an E. coli
protease (Table 1, Fig. 1).
Characterization of the NC–PR junction by cleavage
of oligopeptides. Decapeptides homologous to the wild
type (wt) or CS1 NC–PR junction were incubated with
purified ASLV PR. PR activity was followed by disappear-
ance of substrate and the generation of two hydrolysis
products. As shown in Fig. 2, the wt junction (Figs. 2C
and 2F), but not the CS1 oligopeptide (Figs. 2B and 2E)
was cleaved by purified ASLV protease.
To determine whether substitution of additional amino
acid residues at the NC–PR junction would convert the
decapeptide into a stable substrate for PR, the Ser (posi-
tion P1) was replaced with Arg. This did not result in a
reduced rate of hydrolysis (Figs. 2A and 2D), but rendered
the decapeptide even more susceptible to ASLV PR.
Early release of PR from its precursors may demand
that the junction between PR and the adjacent protein
within the Gag precursor be more susceptible to PR hydro-
lysis than other cleavage sites. We compared the rates of
hydrolysis of the NC–PR and RT–IN decapeptides and
found that they were equally sensitive to cleavage by puri-
TABLE 1
Expression of ASLV Proteins in E. coli
Expression plasmids PR NC
NC PR
NC-PR CA MA
Cleavage products identified by
Western blotting
NC PR
NCCAP10MA PR
NCCAP10MA
CAP10MA
PR
NC PR
NC PR
NC PR
CAP10MA NC PR
1
2
1
2
2
2
2
2
2
2
1
2
2
2
1
1
1
2
1
2
2
2
2
2
1
1
1
2
1
1
1
1
2
2
1
2
2
2
1
1
CS2
CS2
CS1
CS1
Ile
Ile
Note. The table presents the various proteins expressed in E. coli. 
The approximate positions of the Cs1 and CS2 mutations, and of the 
Ile37 mutation, at the PR active site, are indicated. The cleavage 
products identified by Western blotting with specific antisera to PR, NC, 
CA, and MA appear in the right panel. fied ASLV PR (Fig. 3). Furthermore, upon testing the sus-
ceptibility to PR activity of chimeric oligopeptides derived
sium phosphate buffer, pH 5.6, containing 7.5% glycerol,
5 mM dithiothreitol, 1 mM EDTA, 0.2% Nonidet P-40, 2 M
NaCl, and 0.5 mM decapeptide. The assay mixtures were
incubated at 377, and the reaction was terminated by the
addition of guanidine–hydrochloride (6 M final concen-
tration). After detection by reverse-phase HPLC, the
cleavage product peaks were integrated, and the kinetic
parameters were determined according to data obtained
from a substrate which had undergone less than 20%
cleavage.
Antibodies. Antisera against ASLV CA were prepared
by immunizing rabbits with Nonidet P-40 disrupted puri-
fied Pr-C virions. Antisera against ASLV PR and NC were
prepared by immunizing rabbits with purified PR ex-
pressed in bacteria. Anti-MA was kindly supplied by
V. M. Vogt (Cornell University, NY).
RESULTS
Mutations in the NC/PR junction prevent autocatalysis.
It is possible to express ASLV gag (which includes PR)
in E. coli by inserting the appropriate sequence of the
FIG. 2. Cleavage reaction of oligopeptides corresponding to NC/PRASLV genome into an expression plasmid. As shown in
junction. Ten nmol of oligopeptides were treated with 20 pmol of puri-
Fig. 1, upon expression in E. coli, NC-PR is cleaved and fied ASLV PR (D–F), or left untreated (A–C), and incubated for 8 hr at
releases PR and NC, as previously demonstrated 377. Cleavage reactions (20 ml) were terminated by the addition of
guanidine hydrochloride (6 M) and separated by reverse phase HPLC,(Burstein et al., 1992; Kotler et al., 1988b). To test the
on a C18 column (Lichrospher, 250 1 4 mm), using a gradient of 5–activity of the PR linked to the adjacent NC protein, two
60% (vol/vol) acetonitrile in 0.1% aqueous TFA at a flow rate of 1 ml/mutations, CS1 and CS2 , were introduced into the ASLV min. Absorbance at 220 nm was recorded. (A and D) NC/PR (Arg) Pro
genome at the sequence encoding the PR cleavage site Pro Ala Val Arg—Leu Ala Met Thr Met; (B and E) NC/PR (Ile) Pro Pro
between NC and PR. Both mutations prevented cleavage Ala Val Ile—Leu Ala Met Thr Met; (C and F) NC/PR (wt) Pro Ala Val
Ser—Leu Ala Met Thr Met. S, substrate; P, product.between NC and PR. NC and PR remained joined when
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whereas free PR and NC were not detected (Figs. 4A
and 4C). Expression of the pSJHgag constructs in bacte-
rial cells resulted in the accumulation of NC–PR fusion
protein (Figs. 4A and 4C). Thus, the cleavage site muta-
tions, as well as the PRIle mutation, prevented the release
of PR and NC proteins from the viral precursors. Very
faint bands of proteins, which comigrated with the NC–
PR fusion proteins, also appeared in extracts of cells
expressing pSJHgag PR37Ile. Our results indicate that PR,
when fused to NC, is active in the processing of the Gag
precursor expressed in bacterial cells.
ASLV PR fusions appropriately cleave specific pep-
tides. We measured the ability of the fused ASLV PR to
cleave two synthetic peptide substrates, one containing
the junction sequence between NC and PR (NC–PR) and
the other including the junction sequence between X2
FIG. 3. Comparison of NC/PR, RT/IN cleavage rates and of their
and NC (X2–NC) (X2 is a small peptide between CA andchimeric decapeptides by ASLV PR. Synthetic decapeptides homolo-
NC). These decapeptides were cleaved by E. coli extractsgous to NC/PR, RT/IN, NC/IN, and RT/IN were treated with purified
ASLV PR as described in the legend of Fig. 2. Cleavage rate was expressing the wt NC–PR (Fig. 5A). The two synthetic
calculated as percentage substrate cleaved by the enzyme after 8 hr peptides were not cleaved by control E. coli extracts,
of incubation at 377. (Bac Ex) Ile –Ala–Ala–Ala–Met***Ser–Ser–Ala – extracts of E. coli expressing NC–PR with a mutation at
Ile –Gln–Pro; (NC/PR) Pro Pro Ala Val Ser—Leu Ala Met Thr Met; (RT/
the active site (NC–PR37Ile), or those bearing mutationsIN) Thr Phe Gln Ala Tyr—Pro Leu Arg Glu Ala; (NC/IN) Pro Pro Ala
at the cleavage site (NC–RR CS1 and NC–PR CS2) (Fig.Val Ser—Pro Leu Arg Glu Ala; (RT/PR) Thr Phe Gln Ala Tyr—Leu Ala
Met Thr Met; (Bac Ex is a peptide that does not undergo cleavage).
from these peptides, the results show that the chimeric
oligopeptide NC–IN was not cleaved, whereas the recip-
rocal decapeptide RT–PR was hydrolyzed at the same
rate as the wt NC–PR oligopeptide (Fig. 3).
Processing of Gag precursor by NC–PR fusion protein.
The active site mutation (PR37Ile), or the cleavage site
mutations between NC and PR (CS1 and CS2), were
introduced into expression plasmid pSJHgag. The organi-
zation of the gag region of the ASLV genome and the
relationship of the fragments cloned into the expression
plasmids are presented in Table 1. Synthesis of the ASLV
Gag proteins in this expression system depends upon
the presence of T7 polymerase that, following induction,
causes the accumulation of PR, NC, CA, and MA proteins,
which comigrate with authentic viral proteins (gel electro-
phoresis). MA extracted from the viral preparations re-
solved into several bands (Fig. 4). These data confirm an
earlier report demonstrating that the precursor protein is
accurately processed in this system (Mermer et al., 1983).
The pSJHgag plasmid containing a mutation at the active
site of PR (PR37Ile) did not yield free PR, CA, NC, or MA,
although a number of ASLV Gag proteins of higher mo-
lecular weight (Mr : 30–65 kDa) were detected (Figs. 4A –
4D). These proteins may originate in inaccurate initiation FIG. 4. Expression and processing of ASLV polypeptides in E. coli.
or termination during translation of the viral precursors Lysates of E. coli strains expressing the indicated polyproteins (see
or in nonspecific cleavage by bacterial proteases. Table 1 for a more complete description of the ASLV polypeptides)
were fractionated on 15% SDS–polyacrylamide gels and transferred toEach of the two cleavage site mutations between NC
nitrocellulose filters. ASLV polypeptides were detected following theirand PR was inserted into a pSJHgag plasmid [PSJHgag
reaction with the indicated antisera (A, anti-PR; B, anti-CA; C, anti-NC;
PRCS1 and PSJHgag PRCS2]. E. coli transformed with either D, anti-MA) by the addition of I125-protein A. B and D include control
of the mutated plasmids accumulated free CA and MA lanes containing Schmidt–Ruppin virus type A harvested from infected
cultures. Uninduced, extracts from uninduced E. coli.proteins following induction of T7 (Figs. 4B and 4D),
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plete Gag or Gag-Pol polyproteins. PRs might be active
as part of an intact precursor, as in ASLV PR, which is
part of both the Gag and Gag-Pol polyproteins. Due to
the fact that mammalian virus Gag is devoid of PR, we
cannot exclude the possibility that in some cases this
polyprotein is hydrolyzed by free PR.
It has been suggested that synthetic peptide substrates
containing the NC–PR junction sequences are more
readily cleaved by PR than are other peptides homologous
to the Gag-Pol cleavage sites (Burstein et al., 1992). We
found that synthetic peptides mimicking the NC–PR and
RT–IN junctions are similarly cleaved, with no evident
preference for the NC–PR junction. However, our results
demonstrate that the amino acid residues located on the
PR side of the NC–PR junction (P1* to P5*) determine the
accessibility of the substrate to PR, since both NC–PR
and RT–PR (chimeric substrate) oligopeptides are readily
cleaved by the enzyme. Indeed, when the PR side was
replaced by IN sequence, this synthetic peptide was re-
fractory to hydrolysis. Moreover, substitution of Arg for Ser
(position P1) in the NC–PR decapeptide did not affect the
rate of hydrolysis of the peptide.
We also found that E. coli extracts containing NC– PR
fusions (CS1 and CS2) were proved to be enzymatically
inactive, while similar extracts containing these NC– PR
fusions in the Gag precursor polyprotein were active.
The NC–PR fusion protein, as expressed in the bacterial
cell, is probably unable to refold and/or undergo dimer-
ization, whereas the NC–PR fusion, expressed as part
of the complete precursor, is able to refold appropriately
FIG. 5. Comparison of the proteolytic activity of E. coli extracts con- and form dimers, thereby becoming enzymatically active.
taining Gag protein segments. Reaction mixtures containing ASLV X2/ We showed that cleavage of the peptides is entirely
NC and NC/PR peptides were incubated with E. coli extracts expressing
dependent on the presence of an ASLV PR in the GagNC-PR proteins (A) or Gag polyproteins (B) at 377. Protease activity
protein, and that the activity of extracts containing thewas calculated as percentage of substrate cleaved after 60 min of
NC–PR fusions (Gag-CS1 and Gag-CS2) is indistinguish-incubation.
able from that of those containing the wt NC–PR. How-
ever, these assays are not sufficiently quantitative to
5A). However, extracts of wt Gag polyproteins (see Table allow categorical statements to be made about the spe-
1), which contain PR, effectively cleaved both peptides cific activity of the PR fusions relative to that of free PR.
(Fig. 5B). In addition, the synthetic peptides were also Unfortunately, determination of the kinetics of synthetic
hydrolyzed by extracts containing Gag proteins with the peptide hydrolysis is not necessarily an adequate gauge
CS1 or CS2 mutation. The level of PR activity in the Gag for measuring PR activity, as protein folding or dimeriza-
extracts containing NC–PR CS2 and CS2 was essentially tion of the precursor molecules could constitute the rate-
similar to that obtained with bacterial extracts including limiting step the processing of the polyprotein. We are
the wt Gag protein. Although the assay used is not strictly now purifying the fusion proteins in order to accurately
quantitative, the results suggest that at least some of the measure their enzymatic activity.
PR fusions display enzymatic activities comparable with Burstein et al. (1992) previously demonstrated that
those of free PR. when transfected into eukaryotic cells, viral DNA con-
taining the CS2 allowed neither processing of the viral
precursor nor release of RT-containing particles. TheyDISCUSSION
suggested that ‘‘PR must first be released from its precur-
sor before it can attack other sites in the Gag and Gag-HIV-1 and ASLV are not closely related viruses. Yet,
the fact that both their proteases are enzymatically active Pol polyproteins and that the cleavage at the NC–PR
junction is a prerequisite for the initiation of PR-directedwhen linked to the proteins that lie upstream, suggests
that other retroviral PRs are likely to share this property processing.’’ The present results do not support this pos-
tulate as they indicate that the NC–PR fusion protein is(Kotler et al., 1992). Our data also lead us to conjecture
that the PRs should be active in the context of the com- active as part of the Gag polyprotein expressed in bacte-
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blocked by a mutation at the NC-PR cleavage site. J. Virol. 66, 1781–rial cells. However, in agreement with Burstein et al.
1785.(1992), we found that fused NC–PR proteins prevented
Casadaban, M. J., and Cohen, S. N. (1980). Analysis of gene control
virus production in QT-6 cells (results not shown). signals by DNA fusion and cloning in E. coli. J. Mol. Biol. 138, 179–
Why NC–PR fusion proteins are active in bacterial 207.
Co, E., Koelsch, G., Lin, Y., Hartsuck, J. A., and Tang, J. (1994). Proteolyticcells, but not in avian and mammalian cells is not clear.
processing mechanism of a miniprecursor of the aspartic proteaseSeveral explanations are forthcoming: (i) The concentra-
of human immunodefiency virus type 1. Biochemistry 33, 1248–1254.tion of the expressed viral proteins is higher in bacterial
Copeland, T. D., and Oroszlan, S. (1988). Genetic locus, primary struc-
cells, leading to early dimerization and refolding of the ture, and chemical synthesis of human immunodeficiency virus prote-
Gag polyprotein and activation of PR. (ii) In eukaryotic ase. Gene Anal. Tech. 5, 109–115.
Craven, R. C., Bennett, R. P., and Wills, J. W. (1991). Role of the aviancells, PR activation occurs in the later stages of virus
retroviral protease in the activation of reverse transcriptase duringassembly and release. Therefore, the mutation would
virion assembly. J. Virol. 65, 6205–6217.interfere with the appropriate folding only when the pre-
Crowl, R., Seamans, C., Lomedico, P., and McAndrew, S. (1985). Versa-
cursors are already packaged in the virions. This delay tile expression vector for high-level synthesis of cloned gene prod-
does not take place in bacterial cells, where folding and ucts in Escherichia coli. Gene 38, 31–38.
Kotler, M., Katz, R. A., Danho, W., Leis, J., and Skalka, A. M. (1988a).activation occur in the cytoplasm. (iii) Processing of viral
Synthetic peptides as substrates and inhibitors of a retroviral prote-proteins in eukaryotic cells depends on anchorage of
ase. Proc. Natl. Acad. Sci. USA 85, 4185–4189.the precursors to the outer cell membrane via the MA
Kotler, M., Katz, R. A., and Skalka, A. M. (1988b). Activity of avian retrovi-
proteins. It is conceivable that mutations at the NC–PR rus protease expressed in Escherichia coli. J. Virol. 62, 2696–2700.
junction interfere with this securement, thereby pre- Kotler, M., Danho, W., Katz, R. A., Lies, J., and Skalka, A. M. (1989).
Avian retroviral protease and cellular aspartic proteases are distin-venting cleavage. In bacterial cells, processing is inde-
guished by activities on peptide substrates. J. Biol. Chem. 264, 3428–pendent of acetylation or myristylation of MA, enabling
3435.the activation of PR to take place in the bacterial cyto-
Kotler, M., Arad, G., and Hughes, S. (1992). Human immunodeficiency
plasm. (iv) It is possible that the first cleavage event in virus type 1 gag-protease fusion proteins are enzymatically active.
the assembled virion occurs intramolecularly, in cis, at J. Virol. 66, 6781–6783.
Mermer, B., Malamy, M., and Coffin, J. M. (1983). Rous sarcoma virusthe NC–PR junction, while in bacterial cells the hydroly-
contains sequences which permit expression of the gag gene insis of Gag proceeds by cis and trans mechanisms, in no
Escherichia coli. Mol. Cell. Biol. 3, 1746–1748.definite order. The results presented here and in our
Morinaga, Y., Franceschini, T., Inouye, S., and Inouye, M. (1984). Im-
previous report (Kotler et al., 1992) strongly suggest that provement of oligonucleotide-directed mutagenesis using double-
the release of PR is not a prerequisite for processing of stranded plasmid DNA. Bio/Technol. 2, 636–639.
Oertle, S., Bowles, N., and Spahr, P. F. (1992). Complementation studiesthe viral precursors.
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